1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The RAREis Global Advocate Grant is a grant from Amgen that supports and empowers the rare disease community by funding nonprofit organizations working to advance rare disease advocacy, awareness, and patient support. The program recognizes the critical role that patient advocacy organizations play in improving the lives of individuals and families affected by rare conditions.
The 2025 application cycle is now closed, with recipients to be announced in fall 2025. Starting in 2026, the program will shift to focus exclusively on U.S.-based organizations. Eligible applicants are nonprofit organizations supporting rare disease communities.
Grant amounts vary based on project scope and organizational need.
Get alerted about grants like this
Save a search for “Amgen” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
2025 #RAREis Global Advocate Grant 2025 #RAREis Global Advocate Grant A program by Amgen to support and empower the rare disease community around the world!! Thank you for your interest in the #RAREis Global Advocate Grant. The 2025 application is now closed, and recipients will be announced in the fall.
If you have any questions, please contact rareconnect@amgen. com . Thank you!
In 2026, the #RAREis Global Advocate Grant program will shift to focus on supporting U.S.-based organizations. We deeply value the passion and contributions of our global advocacy partners and extend our heartfelt thanks for your continued support and understanding as we align our program for future impact. You are Leaving RAREisCommunity.
com You are now leaving the #RAREis™ Community website. Amgen is not responsible for content or availability of third-party sites. Return to RAREisCommunity.
com
Based on current listing details, eligibility includes: Nonprofit organizations supporting rare disease communities. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program